Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Options -- Ignore unavailable to you. Want to Upgrade?

To: the options strategist who wrote (4949)	3/14/2000 12:09:00 PM
From: the options strategist	Respond to of 8096

DoK, forget my question. Going down too fast for me anyway. Will wait.

To: the options strategist who wrote (4949)	3/14/2000 9:10:00 PM
From: steve mamus	Read Replies (2) \| Respond to of 8096

I am starting to remember why I hated biotechs for years. The sector to me seems very dicey at the moment. The problem with the pharmaceutical industry and biotechs is the government. The sector looks a bit more problematic after the festivities of today. It is always something - a bad FDA study (Chiron), the socialization of the genome project (the whole biotech industry), the govt won't pay for a product or threatens very low reimbursement (the whole industry). I think the sector remains interesting but I could be give a very wide berth on option plays and not get too concentrated in the sector or an individual name. That would a stop closer to destroying a significant amount of your net worth. DoK